Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer

We aim to identify predictors of therapy-related myeloid neoplasms (t-MN) in patients with breast cancer (BC) and cytopenias to determine the timing of bone marrow biopsy (BMBx). Patients with BC and cytopenias who were referred for BMBx between 2002-2018 were identified using the Memorial Sloan Ket...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrone, Giulia, Gaulin, Charles, Derkach, Andriy, Kishtagari, Ashwin, Robson, Mark E., Parameswaran, Rekha, Stein, Eytan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Myelodysplastic Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827166/
https://www.ncbi.nlm.nih.gov/pubmed/35770528
http://dx.doi.org/10.3324/haematol.2021.280437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827166/
https://www.ncbi.nlm.nih.gov/pubmed/35770528
http://dx.doi.org/10.3324/haematol.2021.280437

Ejemplares similares